No Data
No Data
No Data
No Data
No Data
Earnings Call Summary | NUMINUS WELLNESS INC(NUMIF.US) Q2 2024 Earnings Conference
The following is a summary of the Numinus Wellness Inc. (NUMIF) Q2 2024 Earnings Call Transcript:Financial Performance:Numinus reported Q2 2024 revenue of $5 million, down from $5.9 million in the pre
moomoo AIApr 15 20:54 ET · Conference Call
Press Release: Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results PR Newswire VANCOUVER, BC, April 12, 2024 Q2 Fiscal 2024 Highlights -- Cash position of $6.6 million as of February 29, 2024
Dow JonesApr 12 19:49 ET
Numinus Wellness Inc. Closes $6 Million Bought Deal Public Offering
Stockhouse Feb 16 10:29 ET
Press Release: Numinus Wellness Inc. Congratulates Lykos Therapeutics on FDA Acceptance of New Drug Application for MDMA-Assisted Therapy for PTSD
Numinus Wellness Inc. Congratulates Lykos Therapeutics on FDA Acceptance of New Drug Application for MDMA-Assisted Therapy for PTSD Canada NewsWire VANCOUVER, BC, Feb. 14, 2024 Numinus Welcomes Psy
Dow JonesFeb 14 10:39 ET
Numinus Wellness Inc. Announces $6 Million Bought Deal Public Offering With Leads Orders From MAPS and Integrated V.C.
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia
GlobeNewswireFeb 1 16:38 ET
Press Release: Numinus Wellness Inc. Announces First Quarter Fiscal 2024 Results
Numinus Wellness Inc. Announces First Quarter Fiscal 2024 Results PR Newswire VANCOUVER, BC, Jan. 15, 2024 Q1 Fiscal 2024 Highlights -- Gross profit of $2.1 million, an 18.8% increase over Q4 2
Dow JonesJan 15 17:00 ET
No Data
No Data
sonofabiscuit : I'm wondering the same thing